# Efficacy of Orosol® in the Treatment of Chemo- and Radiation-induced Mucositis.

> **NCT05161091** · NA · RECRUITING · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 54 (estimated)

## Conditions studied

- Oral Mucositis

## Interventions

- **DEVICE:** Topical application of Orosol®
- **DEVICE:** Topical application of Placebo comparator

## Key facts

- **NCT ID:** NCT05161091
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-22
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2024-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05161091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05161091, "Efficacy of Orosol® in the Treatment of Chemo- and Radiation-induced Mucositis.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05161091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*